Insiders · RVLP

RVLP insider transactions

RVL Pharmaceuticals plc (RVLP) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

RVLP insiders

Everyone who has filed a Form 3, 4, 5 or 144 at RVL Pharmaceuticals plc, latest first. Follow anyone to get their next filing.

• Foundation Harsaul10% owner-$801K
• Altchem Ltd10% owner-$801K
• Avista Healthcare Partners GP, Ltd.10% owner
• Alisa LaskDirector, since August 2022
• Michael J. DeBiasiDirector
• Gregory L CowanDirector
• James SchaubOfficer
• Christopher KleinOfficer
• David F BurgstahlerDirector, 10% owner
• Sriram VenkataramanDirector, 10% owner
• Avista Capital Partners III GP, L.P.10% owner
• Athyrium Opportunities IV Acquisition 2 LP10% owner, since August 2022
• Tina Marie deVriesOfficer
• Michael DePetrisOfficer, since April 2022
• Andrew J. EinhornOfficer

Recent Form 3, 4, and 5 filings for RVLP

• 1112d
  Harsaul Foundation sold $580,147 worth of Ordinary Shares (14,122,659 units at $0.04) (SEC Form 4)

  4 - RVL Pharmaceuticals plc (0001739426) (Issuer)
• 1112d
  Altchem Ltd sold $580,147 worth of Ordinary Shares (14,122,659 units at $0.04), decreasing direct ownership by 74% to 4,941,101 units (SEC Form 4)

  4 - RVL Pharmaceuticals plc (0001739426) (Issuer)
• 1115d
  Harsaul Foundation sold $221,031 worth of Ordinary Shares (3,421,537 units at $0.06) (SEC Form 4)

  4 - RVL Pharmaceuticals plc (0001739426) (Issuer)
• 1115d
  Altchem Ltd sold $221,031 worth of Ordinary Shares (3,421,537 units at $0.06), decreasing direct ownership by 15% to 19,063,760 units (SEC Form 4)

  4 - RVL Pharmaceuticals plc (0001739426) (Issuer)
• 1179d
  SEC Form 4: Avista Healthcare Partners Gp, Ltd. disposed of 23,730,864 units of Ordinary Shares

  4 - RVL Pharmaceuticals plc (0001739426) (Issuer)
• 1182d
  SEC Form 4: Lask Alisa covered exercise/tax liability with 12,000 units of Ordinary Shares, decreasing direct ownership by 10% to 112,557 units

  4 - RVL Pharmaceuticals plc (0001739426) (Issuer)
• 1216d
  SEC Form 4 filed by Debiasi Michael J.

  4 - RVL Pharmaceuticals plc (0001739426) (Issuer)
• 1216d
  SEC Form 4 filed by Cowan Gregory L

  4 - RVL Pharmaceuticals plc (0001739426) (Issuer)
• 1216d
  SEC Form 4 filed by Lask Alisa

  4 - RVL Pharmaceuticals plc (0001739426) (Issuer)
• 1266d
  SEC Form 4 filed by Schaub James

  4 - RVL Pharmaceuticals plc (0001739426) (Issuer)
• 1266d
  SEC Form 4 filed by Klein Christopher

  4 - RVL Pharmaceuticals plc (0001739426) (Issuer)
• 1378d
  SEC Form 4: Burgstahler David F disposed of 1,032,995 units of Ordinary Shares

  4 - RVL Pharmaceuticals plc (0001739426) (Issuer)
• 1378d
  SEC Form 4: Venkataraman Sriram disposed of 1,032,995 units of Ordinary Shares

  4 - RVL Pharmaceuticals plc (0001739426) (Issuer)
• 1378d
  SEC Form 4: Avista Capital Partners Iii Gp, L.P. disposed of 1,032,995 units of Ordinary Shares

  4 - RVL Pharmaceuticals plc (0001739426) (Issuer)
• 1382d
  SEC Form 4: Klein Christopher covered exercise/tax liability with 9,608 units of Ordinary Shares, decreasing direct ownership by 5% to 186,020 units

  4 - RVL Pharmaceuticals plc (0001739426) (Issuer)
• 1382d
  SEC Form 4: Schaub James covered exercise/tax liability with 9,608 units of Ordinary Shares, decreasing direct ownership by 2% to 530,412 units

  4 - RVL Pharmaceuticals plc (0001739426) (Issuer)
• 1549d
  SEC Form 4: Lask Alisa was granted 75,000 units of Ordinary Shares, increasing direct ownership by 785% to 84,557 units

  4 - RVL Pharmaceuticals plc (0001739426) (Issuer)
• 1549d
  SEC Form 3: New insider Lask Alisa claimed ownership of 9,557 units of Ordinary Shares

  3 - RVL Pharmaceuticals plc (0001739426) (Issuer)
• 1549d
  SEC Form 3: New insider Athyrium Opportunities Iv Acquisition 2 Lp claimed ownership of 14,600,444 units of Ordinary Shares

  3 - RVL Pharmaceuticals plc (0001739426) (Issuer)
• 1633d
  SEC Form 4: Devries Tina Marie covered exercise/tax liability with 5,447 units of Ordinary Shares, decreasing direct ownership by 4% to 136,141 units

  4 - RVL Pharmaceuticals plc (0001739426) (Issuer)
• 1633d
  SEC Form 4: Klein Christopher covered exercise/tax liability with 6,127 units of Ordinary Shares, decreasing direct ownership by 3% to 195,628 units

  4 - RVL Pharmaceuticals plc (0001739426) (Issuer)
• 1633d
  SEC Form 4: Schaub James covered exercise/tax liability with 6,273 units of Ordinary Shares, decreasing direct ownership by 2% to 390,020 units

  4 - RVL Pharmaceuticals plc (0001739426) (Issuer)
• 1661d
  SEC Form 3 filed by new insider Depetris Michael

  3 - RVL Pharmaceuticals plc (0001739426) (Issuer)
• 1747d
  SEC Form 4: Einhorn Andrew J. covered exercise/tax liability with 9,607 units of Ordinary Shares, decreasing direct ownership by 6% to 141,473 units

  4 - RVL Pharmaceuticals plc (0001739426) (Issuer)
• 1747d
  SEC Form 4: Klein Christopher covered exercise/tax liability with 9,607 units of Ordinary Shares, decreasing direct ownership by 5% to 201,755 units

  4 - RVL Pharmaceuticals plc (0001739426) (Issuer)
• 1747d
  SEC Form 4: Devries Tina Marie covered exercise/tax liability with 9,607 units of Ordinary Shares, decreasing direct ownership by 6% to 141,588 units

  4 - RVL Pharmaceuticals plc (0001739426) (Issuer)
• 1747d
  SEC Form 4: Schaub James covered exercise/tax liability with 9,607 units of Ordinary Shares, decreasing direct ownership by 2% to 396,293 units

  4 - RVL Pharmaceuticals plc (0001739426) (Issuer)